|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |||||||
| 化学式 | C23H32N2O2 |
||||||||||
| 分子量 | 368.51 | CAS No. | 1429054-28-3 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 15 mg/mL (40.7 mM) | ||||||||
| Ethanol | 5 mg/mL (13.56 mM) | ||||||||||
| Water | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | IDF-11774 is a hypoxia-inducible factor-1 (HIF-1) inhibitor. It reduces the HRE-luciferase activity of HIF-1α (IC50 = 3.65 μM) and blocks HIF-1α accumulation under hypoxia in HCT116 human colon cancer cells. |
|---|---|
| in vitro | IDF-11774 inhibits the accumulation of HIF-1α in vitro and in vivo in colorectal carcinoma HCT116 cells under hypoxic conditions. The treatment of this compound suppresses angiogenesis of cancer cells by reducing the expression of HIF-1 target genes, reduces glucose uptake, thereby sensitizing cells to growth under low glucose conditions, and decreases the extracellular acidification rate (ECAR) and oxygen consumption rate of cancer cells. Therefore, this chemical reduces cancer cell growth through the regulation of cancer glycolytic metabolism and energy production[1]. |
| in vivo | This compound exhibited substantial anticancer efficacy in mouse models containing KRAS, PTEN, or VHL mutations, which often occur in malignant cancers[1]. |
| 細胞アッセイ | 細胞株 | HCT116 cells |
|---|---|---|
| 濃度 | 5, 10, 20 μM | |
| 反応時間 | 18 h | |
| 実験の流れ | -- |
|
| 動物実験 | 動物モデル | Balb/c nude mice bearing tumors (100 mm3) formed from HCT116 cells (1 × 107) expressing HRE-luciferase by subcutaneous injection |
| 投薬量 | 50 mg/kg | |
| 投与方法 | p.o. |
|
| HIF1A-mediated pathways promote euploid cell survival in chromosomally mosaic embryos [ Elife, 2025, 13RP101912] | PubMed: 41086100 |
| Targeting hypoxia-inducible factor-1 in a hypoxidative stress model protects retinal pigment epithelium cells from cell death and metabolic dysregulation [ Cell Death Discov, 2025, 11(1):380] | PubMed: 40813365 |
| Inhibition of Endothelial HIF-1α by IDF-11774 Attenuates Retinal Neovascularization and Vascular Leakage [ Invest Ophthalmol Vis Sci, 2025, 66(9):47] | PubMed: 40668060 |
| Metabolic imprinting drives epithelial memory during mucosal fungal infection [ bioRxiv, 2025, 2025.07.11.664387] | PubMed: 40791350 |
| HIF1A contributes to the survival of aneuploid and mosaic pre-implantation embryos [ bioRxiv, 2024, 2023.09.04.556218] | PubMed: 39071426 |
| Targeting APLN/APJ restores blood-testis barrier and improves spermatogenesis in murine and human diabetic models [ Nat Commun, 2022, 13(1):7335] | PubMed: 36443325 |
| Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-β1 Upregulation to Trigger Osteomyelitis [ mSystems, 2022, 7(4):e0038022] | PubMed: 35852344 |
| Trabectedin induces ferroptosis via regulation of HIF-1α/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells [ Chem Biol Interact, 2022, 369:110262] | PubMed: 36396105 |
| Inhibition of hypoxia-inducible factor-1α alleviates acinar cell necrosis in a mouse model of acute pancreatitis [ Biochem Biophys Res Commun, 2021, 572:72-79] | PubMed: 34358966 |
| Secreted frizzled-related protein 2 inhibits the proliferation and metastasis of human colorectal cancer cell line SW480 [ Basic & Clinical Medicine, 2020, 40(9): 1212-1217] | PubMed: None |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。